Targets of Immune Regeneration in Rheumatoid Arthritis

Slides:



Advertisements
Similar presentations
The Mre11 complex is required for ATM activation and the G 2 /M checkpoint Carson, C.T. et al The EMBO J (Vol. 22), 2003.
Advertisements

ATM, Ataxia Telangiectasia, & Cancer
1 H2AX: functional roles and potential applications.
. Cell Division- Regulation of the Cell Cycle. Target #25-I can explain the external factors that are involved in cell cycle regulation Both external.
HOW DO CHECKPOINTS WORK? Checkpoints are governed by phosphorylation activity controlled by CDK’s (cyclin dependent kinases) Checkpoints are governed.
DNA Replication ORC anneals to origin ORC recruits MCM MCM recruits Cdc45p Cdc45p recruits pol  /primase complex RFC displaces pol  and recruits PCNA.
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
Mechanism of Action of Colchicine in the Treatment of Gout
Prediction of Response to Targeted Treatment in Rheumatoid Arthritis
Targeting the DNA Damage Response in Cancer
Figure: Caption: The cell cycle is controlled at several checkpoints, including one at the G2/M transition, and another in late G1 phase before.
Nat. Rev. Rheumatol. doi: /nrrheum
Pathophysiology of the metabolic syndrome
Tumor Promoting Inflammation
Bart Staels, PhD  The American Journal of Medicine 
d-Lactic Acidosis and Selected Cerebellar Ataxias
Prevention of ischemia-reperfusion injury in cardiac surgery: Therapeutic strategies targeting signaling pathways  Kay Maeda, MD, PhD, Marc Ruel, MD,
Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era  Joon H. Uhm, MD, Alyx B. Porter,
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Latest Advances in Chemotherapeutic, Targeted, and Immune Approaches in the Treatment of Metastatic Melanoma  Darshil J. Shah, MD, MPH, Roxana S. Dronca,
Nat. Rev. Nephrol. doi: /nrneph
Corticosteroids in the Treatment of Alcohol-Induced Rhabdomyolysis
Targets of Immune Regeneration in Rheumatoid Arthritis
Is Hepatitis C Virus Carcinogenic?
Beyond Making Ends Meet: DNA-PK, Metabolism, and Aging
Beyond Making Ends Meet: DNA-PK, Metabolism, and Aging
Targets of Immune Regeneration in Rheumatoid Arthritis
Origin of Chromosomal Translocations in Lymphoid Cancer
Vascular dysfunction in diabetes mellitus
FANCF methylation contributes to chemoselectivity in ovarian cancer
DNA-Damage Response in Tissue-Specific and Cancer Stem Cells
Coming up for air: HIF-1 and mitochondrial oxygen consumption
p53 and Metabolism: The GAMT Connection
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
AMPK Keeps Tumor Cells from Starving to Death
Volume 137, Issue 2, Pages (May 2015)
RNA Processing and Genome Stability: Cause and Consequence
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
Successful and Maladaptive T Cell Aging
Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation—what to do? 
Graeme Hewitt, Viktor I. Korolchuk  Trends in Cell Biology 
Ageing, telomeres, senescence, and liver injury
Metastatic Breast Cancer
Meiotic Checkpoints: Repair or Removal?
ATM Creates a Veil of Transcriptional Silence
Volume 76, Issue 11, Pages (December 2009)
Figure 1 Main triggers of senescence
DNA Double-Strand Breaks Come into Focus
Banking on ATM as a new target in metabolic syndrome
DNA DSB repair signaling pathways through the apical DDR kinases.
Andrew N. Blackford, Stephen P. Jackson  Molecular Cell 
Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus  John E. Gerich, MD  Mayo Clinic Proceedings 
DNA repair: Rad52 – the means to an end
Tobias R. Kollmann, Ofer Levy, Ruth R. Montgomery, Stanislas Goriely 
The DNA Damage Response: Making It Safe to Play with Knives
Graeme Hewitt, Viktor I. Korolchuk  Trends in Cell Biology 
T-Cell Immunity in Acute Coronary Syndromes
Modes of p53 Regulation Cell
Dagmar Simon, Luca Borradori, Hans-Uwe Simon 
Initiating Cellular Stress Responses
Hassanali H. Sewani, MD, Jeffrey T. Rabatin, MD 
Mantle Cell Involvement of the Spleen
ATM function in repair of double-stranded DNA breaks.
Putative roles of HTT and ATXN3 in DNA repair and how HTT and ATXN3 polyglutamine expansions might lead to DNA damage and apoptosis. Putative roles of.
Squamous Cell Carcinoma of the Tongue
Kanad Ghosh, Brian C. Capell  Journal of Investigative Dermatology 
Are Mouse Telomeres Going to Pot?
Tenets of PTEN Tumor Suppression
Airway smooth muscle: A modulator of airway remodeling in asthma
Overcoming ATM Deficiency by Activating the NAD+/SIRT1 Axis
Presentation transcript:

Targets of Immune Regeneration in Rheumatoid Arthritis Philipp J. Hohensinner, PhD, Jörg J. Goronzy, MD, PhD, Cornelia M. Weyand, MD, PhD  Mayo Clinic Proceedings  Volume 89, Issue 4, Pages 563-575 (April 2014) DOI: 10.1016/j.mayocp.2014.01.020 Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 1 Effects of aging on the immune system. Aging reduces immune competence, naive T-cell numbers, CD28 expression, and DNA double-strand repair, resulting in immune cells with increased DNA damage and a proinflammatory signature. DUSP = dual-specificity phosphatase. Mayo Clinic Proceedings 2014 89, 563-575DOI: (10.1016/j.mayocp.2014.01.020) Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 2 Senescence-associated cellular phenotype. Senescence in cells is induced by multiple factors, including repeated cell divisions, mitogenic signals, and DNA damage. Senescent cells are characterized by increased cell size; shortened telomeres; activated checkpoint kinase 2 (Chk2), p53, and p16INK4A; and expression of proinflammatory proteins, including tumor necrosis factor (TNF), monocyte chemotactic protein 1 (MCP1), plasminogen activator inhibitor type 1 (PAI1), and matrix metallopeptidases (MMPs). ATM = ataxia telangiectasia mutated; CDKN2A = cyclin-dependent kinase inhibitor 2A; NBS = Nijmegen breakage syndrome. Mayo Clinic Proceedings 2014 89, 563-575DOI: (10.1016/j.mayocp.2014.01.020) Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 3 Deficits in DNA damage repair and immune aging. A, In healthy CD4 T cells, DNA damage rapidly induces recruitment of the MRN complex, consisting of RAD50, meiotic recombination 11 (MRE11), and Nijmegen breakage syndrome type 1 (NBS1), to the damage site. Complex formation facilitates activation of the kinase ataxia telangiectasia mutated (ATM). The signaling cascade activated by ATM consists of numerous proteins, including phosphorylation of H2AX, activation of BRCA1, and activation of checkpoint kinase 2 (Chk2) and p53. Overall, ATM signaling leads to triggering of the cell cycle checkpoint, with slowing of cell cycle progression and DNA damage repair. In contrast, CD4 T cells from patients with rheumatoid arthritis fail to recruit sufficient MRN complexes, have reduced ATM activation, and lag behind in p53 activation, causing cell cycle prolongation and reduced DNA damage repair in affected T cells. B, Besides activating ATM, the MRN complex is also involved in activating DNA-activated protein kinase catalytic polypeptide (DNA-PKcs). In healthy T cells, binding of Ku70/80 facilitates activation of DNA-PKcs at the double-strand break, resulting in H2AX phosphorylation, DNA ligase IV recruitment, and p53 activation. In rheumatoid arthritis T cells, DNA-PKcs is up-regulated and the concentrations of phosphorylated DNA-PKcs are increased, and Ku70/80 is reduced. This imbalance triggers the stress kinase JNK and with persisting DNA damage mediates apoptosis via the Bim/Bmf pathway. Mayo Clinic Proceedings 2014 89, 563-575DOI: (10.1016/j.mayocp.2014.01.020) Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 4 Metabolic abnormalities in T cells in patients with rheumatoid arthritis (RA). Naive CD4 T cells in patients with RA are characterized by metabolic reprogramming, including a reduction in glycolysis, diminished adenosine triphosphate production, and insufficient autophagy. These defects in energy generation are caused by a failure to induce the major regulatory enzyme of the glycolytic pathway, phosphofructokinase/fructosebiphosphatase (PFKFB3). Consequences of this metabolic reprogramming include an increase in nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) levels, reduced availability of cellular reactive oxygen species (ROS), and increased apoptotic susceptibility. Mayo Clinic Proceedings 2014 89, 563-575DOI: (10.1016/j.mayocp.2014.01.020) Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions